Invention Grant
- Patent Title: Synergistic compositions
-
Application No.: US15594795Application Date: 2017-05-15
-
Publication No.: US09957230B2Publication Date: 2018-05-01
- Inventor: Mukul R. Jain , Suresh Giri , Himanshu M. Kothari , Kaushik Banerjee , Rashmikant Kachhiya
- Applicant: Cadila Healthcare Limited
- Applicant Address: IN Ahmedabad, Gujarat
- Assignee: Cadila Healthcare Limited
- Current Assignee: Cadila Healthcare Limited
- Current Assignee Address: IN Ahmedabad, Gujarat
- Agency: Goodwin Procter LLP
- Priority: IN2276/MUM/2013 20130705
- Main IPC: C07D207/333
- IPC: C07D207/333 ; C07D233/58 ; A61K31/155 ; C07C279/14 ; C07C229/26 ; C07C217/60 ; C07C215/40 ; C07C215/12 ; C07C215/10 ; C07C211/51 ; C07C211/35 ; C07C211/30 ; C07C211/27 ; C07C211/11 ; A61K45/06 ; A61K38/26 ; A61K31/64 ; A61K31/505 ; A61K31/4985 ; A61K31/4015 ; A61K31/40 ; C07D295/027

Abstract:
The present invention describes a synergistic composition comprising of one or more statins, or one or more dipeptidyl peptidase IV (DPP IV) inhibitor or one or more biguanide antihyperglycaemic agent and a PPAR agonist of formula (1a) for the treatment of diabetes, especially non-insulin dependent diabetes (NIDDM) or Type 2 diabetes and conditions associated with diabetes mellitus and to compositions suitable for use in such method. The invention also describes the preparation of such compositions. The present invention also relates to certain novel salts of the PPAR agonist of formula (I), processes for the preparation of: these novel salts and use thereof.
Public/Granted literature
- US20170320823A1 SYNERGISTIC COMPOSITIONS Public/Granted day:2017-11-09
Information query